ARS Pharmaceuticals Inc’s filing revealed that its CHIEF MEDICAL OFFICER Tanimoto Sarina unloaded Company’s shares for reported $1.14 million on Jul 16 ’24. In the deal valued at $11.40 per share,100,000 shares were sold. As a result of this transaction, Tanimoto Sarina now holds 1,547,447 shares worth roughly $15.13 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Lowenthal Richard E sold 100,000 shares, generating $1,140,295 in total proceeds. Upon selling the shares at $11.40, the PRESIDENT AND CEO now owns 1,547,447 shares.
Before that, Tanimoto Sarina sold 100,000 shares. ARS Pharmaceuticals Inc shares valued at $961,725 were divested by the CHIEF MEDICAL OFFICER at a price of $9.62 per share. As a result of the transaction, Tanimoto Sarina now holds 1,496,494 shares, worth roughly $14.64 million.
Raymond James initiated its ARS Pharmaceuticals Inc [SPRY] rating to an Outperform in a research note published on July 25, 2024; the price target was $18. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who increased its forecast for the stock in early March from “a Market perform” to “an Outperform”. William Blair also remained covering SPRY and has increased its forecast on February 20, 2024 with a “an Outperform” recommendation from previously “Mkt perform” rating. William Blair revised its rating on September 20, 2023. It rated SPRY as “a Mkt perform” which previously was an “an Outperform”.
Price Performance Review of SPRY
On Tuesday, ARS Pharmaceuticals Inc [NASDAQ:SPRY] saw its stock jump 4.94% to $9.78. Over the last five days, the stock has lost -10.85%. ARS Pharmaceuticals Inc shares have risen nearly 78.47% since the year began. Nevertheless, the stocks have risen 39.12% over the past one year. While a 52-week high of $11.90 was reached on 07/15/24, a 52-week low of $2.55 was recorded on 01/04/24. SMA at 50 days reached $9.52, while 200 days put it at $7.54. A total of 0.45 million shares were traded, compared to the trading of 0.6 million shares in the previous session.
Levels Of Support And Resistance For SPRY Stock
The 24-hour chart illustrates a support level at 9.39, which if violated will result in even more drops to 8.99. On the upside, there is a resistance level at 10.09. A further resistance level may holdings at 10.39. The Relative Strength Index (RSI) on the 14-day chart is 45.73, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.83, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 67.78%. Stochastics%K at 18.38% indicates the stock is a buying.
The most recent change occurred on January 31, 2023 when Wedbush began covering the stock and recommended ‘”an Outperform”‘ rating along with a $10 price target.
